Combined therapy with indapamide and perindopril but not perindopril alone reduced the risk for recurrent stroke

Affiliations

Comment

David Tirschwell. ACP J Club. 2002 Mar-Apr.

. 2002 Mar-Apr;136(2):51.

No abstract available

Comment on

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
PROGRESS Collaborative Group. PROGRESS Collaborative Group. Lancet. 2001 Sep 29;358(9287):1033-41. doi: 10.1016/S0140-6736(01)06178-5. Lancet. 2001. PMID: 11589932 Clinical Trial.

Mixed models showed no need for initial response monitoring after starting antihypertensive therapy.
Bell KJ, Hayen A, Macaskill P, Craig JC, Neal BC, Irwig L. Bell KJ, et al. J Clin Epidemiol. 2009 Jun;62(6):650-9. doi: 10.1016/j.jclinepi.2008.07.018. Epub 2008 Dec 23. J Clin Epidemiol. 2009. PMID: 19108988 Clinical Trial.
Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
Chalmers J, Joshi R, Kengne AP, Ninomiya T, Bi Y, Bompoint S, Billot L, Patel A; ADVANCE Collaborative Group. Chalmers J, et al. J Hypertens Suppl. 2008 Sep;26(3):S21-7. J Hypertens Suppl. 2008. PMID: 19363849 Review.
Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy.
Bugnicourt JM, Chillon JM, Canaple S, Lamy C, Godefroy O. Bugnicourt JM, et al. Fundam Clin Pharmacol. 2008 Apr;22(2):217-22. doi: 10.1111/j.1472-8206.2008.00570.x. Fundam Clin Pharmacol. 2008. PMID: 18353116
Making PROGRESS in stable patients post stroke or transient ischaemic attack: implications for general practice.
Jackson G. Jackson G. Int J Clin Pract. 2003 Jun;57(5):385-7. Int J Clin Pract. 2003. PMID: 12846342 Review.
Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
Gosse P. Gosse P. Expert Rev Cardiovasc Ther. 2006 May;4(3):319-33. doi: 10.1586/14779072.4.3.319. Expert Rev Cardiovasc Ther. 2006. PMID: 16716093 Review.

The PROGRESS trial three years later: time for a balanced report of effectiveness.
Wennberg R, Zimmermann C. Wennberg R, et al. BMJ. 2004 Oct 23;329(7472):968-70. doi: 10.1136/bmj.329.7472.968. BMJ. 2004. PMID: 15499116 Free PMC article.